Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00169130. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients
ClinicalTrials.gov study NCT06569485. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
ClinicalTrials.gov study NCT06045910. IPD Sharing: YES. Countries: 1. Publications: 0.
Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy
ClinicalTrials.gov study NCT02903810. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
ClinicalTrials.gov study NCT00004086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cell Free DNA in Mature B-cell Lymphoma
ClinicalTrials.gov study NCT04088422. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Aim of This Project is to Verify Whether a Depletion of B Cell Memory Subpopulation ("Marginal-zone-like") CD19 + IgD + CD27 + and CD19 + IgM + CD27 + is a Useful Indicator of Hyposplenism in Pati
ClinicalTrials.gov study NCT03763487. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07133997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HRV-B for Symptom Management in Sickle Cell Patients
ClinicalTrials.gov study NCT03383913. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma
ClinicalTrials.gov study NCT05972720. IPD Sharing: NO. Countries: 1. Publications: 0.
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
ClinicalTrials.gov study NCT05256641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00086775. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT00568815. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
ClinicalTrials.gov study NCT06830759. IPD Sharing: UNDECIDED. Countries: 12. Publications: 0.
BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL
ClinicalTrials.gov study NCT04690595. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of YK012 in B-cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT06580301. IPD Sharing: Not stated. Countries: 1. Publications: 0.
KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07246707. IPD Sharing: NO. Countries: 1. Publications: 0.
Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)
ClinicalTrials.gov study NCT01279707. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04011293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05149391. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.